trending Market Intelligence /marketintelligence/en/news-insights/trending/4DXhXCwx0X2Prk9P7o9gwQ2 content esgSubNav
Log in to other products

 /


Looking for more?

Contact Us
In This List

Vitamin Shoppe profit misses consensus by 22.6% in fiscal Q4

Blog

Global M&A Infographic Q1 2021

Blog

COVID-19 Impact & Recovery: Private Equity

COVID-19 Impact & Recovery: Corporates

Blog

COVID-19 Impact & Recovery: Investment Banking


Vitamin Shoppe profit misses consensus by 22.6% in fiscal Q4

Vitamin Shoppe Inc. said its normalized net income for the fiscal fourth quarter ended Dec. 26, 2015, was 30 cents per share, compared with the S&P Capital IQ consensus estimate of 38 cents per share.

EPS fell 32.7% year over year from 44 cents.

Normalized net income, which excludes unusual gains or losses on a pre- and after-tax basis, was $8.4 million, a decline of 37.3% from $13.4 million in the year-earlier period.

The normalized profit margin fell to 3.4% from 4.6% in the year-earlier period.

Total revenue climbed year over year to $293.5 million from $290.1 million, and total operating expenses grew on an annual basis to $279.5 million from $268.5 million.

Reported net income declined 47.1% on an annual basis to $6.2 million, or 22 cents per share, from $11.8 million, or 39 cents per share.

For the year, the company's normalized net income totaled $2.02 per share, compared with the S&P Capital IQ consensus normalized EPS estimate of $2.10.

EPS declined 11.5% from $2.28 in the prior year.

Normalized net income was $59.0 million, a decline of 15.7% from $69.9 million in the prior year.

Full-year total revenue rose from the prior-year period to $1.27 billion from $1.21 billion, and total operating expenses rose 6.4% year over year to $1.17 billion from $1.10 billion.

The company said reported net income fell 13.3% year over year to $53.2 million, or $1.82 per share, in the full year, from $61.3 million, or $2.00 per share.